Physician
Younossi, Gulam
Younossi, Gulam was paid $3.00M by Medicaid between Jan 2018 and Dec 2024, across 54 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoYOUNOSSI, GULAM
ALEXANDRIA, VA 22311
ALEXANDRIA, VA 22311
33aNPI1801822705assigned 06/23/2006
33bProvider typePediatrics Physician
28Total paid$3.00M
24GClaims126,504
24DCodes billed54
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Virginia
Rank by total paid#60 of 817
Median peer was paid$29K
This provider vs. median102×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,846 | $410K | |
| 2019 | 20,532 | $430K | |
| 2020 | 17,575 | $409K | |
| 2021 | 17,988 | $416K | |
| 2022 | 18,805 | $481K | |
| 2023 | 19,758 | $468K | |
| 2024incomplete | 14,000 | $381K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 21,828 | 17,777 | $1.14M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 9.8% | 4,213 | 3,832 | $294K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.6% | 3,948 | 3,690 | $286K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.1% | 2,777 | 2,416 | $183K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.0% | 2,348 | 2,140 | $180K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.4% | 4,031 | 3,519 | $133K |
| 92551 | 2.4% | 7,930 | 7,234 | $70K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.0% | 7,839 | 7,070 | $61K |
| 90670 | 1.9% | 2,097 | 1,927 | $56K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 4,468 | 2,052 | $54K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.7% | 1,512 | 1,445 | $52K |
| 90686 | 1.7% | 4,639 | 4,364 | $52K |
42 more codes
| 90651 | 1.5% | 1,310 | $45K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 3,598 | $45K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.4% | 3,722 | $42K |
| 90716 | 1.1% | 1,526 | $34K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 395 | $29K |
| 90633 | <1% | 2,014 | $25K | |
| 90707 | <1% | 1,354 | $23K | |
| 90680 | <1% | 1,252 | $21K | |
| 90723 | <1% | 1,329 | $21K | |
| 90648 | <1% | 1,833 | $18K | |
| 90734 | <1% | 754 | $18K | |
| 99173 | <1% | 8,169 | $18K | |
| 90700 | <1% | 1,250 | $14K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 11,557 | $11K |
| 90713 | <1% | 788 | $9K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 84 | $6K |
| 90715 | <1% | 462 | $6K | |
| 87807 | <1% | 425 | $5K | |
| 90697 | <1% | 143 | $4K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 6,101 | $4K |
| 90677 | <1% | 96 | $4K | |
| 90620 | <1% | 127 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 242 | $4K |
| 99381 | <1% | 49 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 43 | $3K |
| 86580 | <1% | 314 | $2K | |
| 90744 | <1% | 185 | $2K | |
| 90621 | <1% | 60 | $2K | |
| 99383 | <1% | 14 | $1K | |
| 94664 | <1% | 133 | $1K | |
| 97802 | <1% | 974 | $1K | |
| 81002 | <1% | 394 | $1K | |
| 90698 | <1% | 54 | $877.00 | |
| 90658 | <1% | 74 | $860.82 | |
| 99177 | <1% | 145 | $461.74 | |
| 90657 | <1% | 31 | $369.30 | |
| 90474 | <1% | 1,192 | $366.96 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 2,979 | $350.96 |
| 99441 | <1% | 13 | $194.75 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 3,508 | $127.28 |
| 94760 | <1% | 61 | $84.89 | |
| 96161 | <1% | 120 | $67.67 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.